ABVCAbvc Biopharma, Inc.
ABVC holders
Who holds Abvc Biopharma, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
Moves this quarter
Added
- Vanguard Capital Management LLC+194.7K$603.3K
- UBS Group AG+105.1K$147.5K
- State Street Corp+18.5K$96.8K
- Geode Capital Management, LLC+8.7K$251K
Reduced
New
- Squarepoint Ops LLC11.4K$12.1K
- Barclays PLC2$2
- SBI Securities Co., Ltd.1$1
- Managers
- 13
- Shares held
- 1.3M
- Value held
- $1.4M
- Opened
- 3
- Closed
- 4
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 569.2K | +52.0% | $603.3K | 0% | Nov 13, 2026 |
| Geode Capital Management, LLC | 236.7K | +3.8% | $251K | 0% | Nov 6, 2026 |
| UBS Group AG | 139.2K | +307.9% | $147.5K | 0% | Nov 10, 2026 |
| Vanguard Fiduciary Trust Co | 97.4K | ±0% | $103.2K | 0% | Nov 13, 2026 |
| State Street Corp | 91.3K | +25.4% | $96.8K | 0% | Nov 12, 2026 |
| BlackRock, Inc. | 56.4K | ±0% | $59.8K | 0% | Nov 13, 2026 |
| Northern Trust Corp | 48.6K | ±0% | $51.6K | 0% | Nov 16, 2026 |
| Panagora Asset Management Inc | 36.7K | ±0% | $38.9K | 0.1% | Nov 12, 2026 |
| Citadel Advisors LLC | 29.4K | −59.2% | $31.2K | 0% | Nov 16, 2026 |
| Squarepoint Ops LLC | 11.4K | New | $12.1K | 0% | Nov 9, 2026 |
| Barclays PLC | 2 | New | $2 | 0% | Nov 6, 2026 |
| Caitong International Asset Management Co., Ltd | 1 | −83.3% | $1 | 0% | Oct 29, 2026 |
| SBI Securities Co., Ltd. | 1 | New | $1 | 0% | Oct 22, 2026 |